Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Analytical similarity assessment of MYL-1402O to reference Bevacizumab.
Goyal P, Vats B, Subbarao M, Honnappa CG, Kabadi P, Rohil S, Bera A, Mehta GR, Pai H, Adhikari L, Tagore R, Sharma S, Venkatachala R, Nair P, Annegowda S, Sahu A, Trivedi S, Shastri N, Gokhale Y, Thomas R, Thakur A, Mohan D, Rao K U, Melarkode R, Ullanat R. Goyal P, et al. Among authors: kabadi p. Expert Opin Biol Ther. 2022 Feb;22(2):271-298. doi: 10.1080/14712598.2021.1973426. Epub 2021 Oct 13. Expert Opin Biol Ther. 2022. PMID: 34465264
Evaluation of physicochemical and biological properties of nonreconstituted MYL-1401O vials, reconstituted MYL-1401O suspension in vial, and diluted MYL-1401O suspension in infusion bags (0.9% saline) for extended duration.
Vats B, Goyal P, Mathew Z, Ghosh R, Babu MN, Jadav RS, Nair AM, Subbarao M, Bera A, Prakash Sadasivappa K, Kabadi P, Sarkar A, Honnappa CG, Patnaik US, Singh A, Parambath AV, Ullanat R. Vats B, et al. Among authors: kabadi p. Expert Opin Biol Ther. 2022 Feb;22(2):299-311. doi: 10.1080/14712598.2021.1917546. Epub 2021 May 2. Expert Opin Biol Ther. 2022. PMID: 33896318
Physicochemical and functional characterization of trastuzumab-dkst, a trastuzumab biosimilar.
Goyal P, Iyer J, Adhikary L, Vats B, Kabadi P, Pai H, Ranayhossaini D, Gouda S, Subbarao M, Mehta G, Saha A, Bera A, Sahu A, Kaur M, Singh A, Marwah A, Reddy Moole PK, Smith J, Melarkode R, Ullanat R. Goyal P, et al. Among authors: kabadi p. Future Med Chem. 2021 Sep;13(18):1531-1557. doi: 10.4155/fmc-2021-0113. Epub 2021 Jul 22. Future Med Chem. 2021. PMID: 34289749
Identification and quantification of product-related quality attributes in bio-therapeutic monoclonal antibody via a simple, and robust cation-exchange HPLC method compatible with direct online detection of UV and native ESI-QTOF-MS analysis.
Sankaran PK, Kabadi PG, Honnappa CG, Subbarao M, Pai HV, Adhikary L, Palanivelu DV. Sankaran PK, et al. Among authors: kabadi pg. J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Dec 1;1102-1103:83-95. doi: 10.1016/j.jchromb.2018.10.019. Epub 2018 Oct 21. J Chromatogr B Analyt Technol Biomed Life Sci. 2018. PMID: 30380467
Design, parallel synthesis of Biginelli 1,4-dihydropyrimidines using PTSA as a catalyst, evaluation of anticancer activity and structure activity relationships via 3D QSAR studies.
Faizan S, Prashantha Kumar BR, Lalitha Naishima N, Ashok T, Justin A, Vijay Kumar M, Bistuvalli Chandrashekarappa R, Manjunathaiah Raghavendra N, Kabadi P, Adhikary L. Faizan S, et al. Among authors: kabadi p. Bioorg Chem. 2021 Dec;117:105462. doi: 10.1016/j.bioorg.2021.105462. Epub 2021 Nov 2. Bioorg Chem. 2021. PMID: 34753059
Rational Design, Synthesis, and In Vitro Neuroprotective Evaluation of Novel Glitazones for PGC-1α Activation via PPAR-γ: a New Therapeutic Strategy for Neurodegenerative Disorders.
Justin A, Mandal S, Prabitha P, Dhivya S, Yuvaraj S, Kabadi P, Sekhar SJ, Sandhya CH, Wadhwani AD, Divakar S, Bharathi JJ, Durai P, Prashantha Kumar BR. Justin A, et al. Among authors: kabadi p. Neurotox Res. 2020 Mar;37(3):508-524. doi: 10.1007/s12640-019-00132-9. Epub 2019 Nov 28. Neurotox Res. 2020. PMID: 31782098